Showing results (481-490 of 505) with videos related to

Sort By:
Pageof 51
Vaccines|October 26, 2024
Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874Dominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Nature Communications|November 29, 2019
Cytoplasmic glycoengineering enables biosynthesis of nanoscale glycoprotein assembliesHanne L P Tytgat, Chia-Wei Lin, Mikail D Levasseur, et al.
Cell|October 18, 1996
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP geneT Holtschke, J Löhler, Y Kanno, et al.
Vaccines|August 29, 2024
Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV SerotypesDominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Vaccines|May 5, 2017
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivaxGustavo Cabral-Miranda, Matthew D Heath, Mona O Mohsen, et al.
Viruses|March 12, 2020
Immunization of Cats against Fel d 1 Results in Reduced Allergic Symptoms of OwnersFranziska Thoms, Stefanie Haas, Aline Erhart, et al.
Vaccines|September 28, 2024
Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle VaccinesDominik A Rothen, Sudip Kumar Dutta, Pascal S Krenger, et al.
Frontiers in Immunology|June 4, 2019
Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-VaccineMona O Mohsen, Monique Vogel, Carsten Riether, et al.
Diseases (Basel, Switzerland)|November 25, 2018
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based VaccinesGustavo Cabral-Miranda, Ahmed M Salman, Mona O Mohsen, et al.
Allergy|April 11, 2022
Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concernDominik A Rothen, Pascal S Krenger, Aleksandra Nonic, et al.
Pageof 51